bpc 157 human clinical trials status fda approval BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded BPC-157 Benefits: Gut, Joints, Muscle,
Description
Sermorelin Acetate - Warnings and Laboratory Tests (FDA Prescribing Information)

This is what makes the wide variation in injection frequency between products possible

When interpreted together with the findings of the STEP 4 withdrawal trial and STEP 1 off-treatment extension study, which both showed weight regain after semaglutide discontinuation (after 20 weeks treatment in STEP 4 and 68 weeks treatment in STEP 1) 23,24 , these results support the benefit of continued semaglutide treatment for sustained weight loss
I.JinX.FurukawaK.HamasakiM.NezuA.OteraH.et al (2016)

tightening of the chest wall muscles occasionally produced shortness of breath
